ArticleJournal of nanobiotechnology2024
A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapy.
Xuelin Xia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it